Journal of Rheumatology

Article	Citations
Is Real-world Evidence Really Real?	69
Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain	52
Drs. Dai and Fan reply	35
Canadian Rheumatology Association Annual Scientific Meeting; RBC Convention Centre (and Virtually); Winnipeg, Manitoba, Canada; February 28–March 2, 2024	33
50th Year of Publication: Revisiting the 1980s	33
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association With HLA-B27 in European and Ibero-American Populations	32
Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry	28
Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada	28
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?	27
A Move Toward Precision: Innovations in Measuring Spinal Mobility in Axial Spondyloarthritis	27
Dr. Gottlieb et al reply	27
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort	27
Remission in Gout: Concepts From a Patient Perspective	27
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease	25
“Gallia est omnis divisa in partes tres”: Social Media Platforms as a New Educational Channel for Pediatric Rheumatology	25
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis: Real-World Data	24
TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition	24
A Reciprocal Machine Learning Approach to Defining Physiologic Compensation of the Synovial Joint in Knee Osteoarthritis	24
Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series	24
Arthritis Mutilans in Jo1 Antisynthetase Syndrome	24
Aneurysmal Disease in Patients With Takayasu Arteritis	23
Is There Relevance of a Positive Rheumatoid Factor in Systemic Sclerosis? A Systematic Review of the Literature	23
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting	22
The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis	22
Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test	22

Risk of Cancer Among Sarcoidosis Patients With Biopsy-verified Nonnecrotizing Granulomatous Inflammation: Population-based Cohort Study	22
Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study	21
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND	20
THE USE OF POLYSIMPTOMATIC DISTRESS SCALE IN A MULTICENTRIC COHORT OF SLE PATIENTS TO IDENTIFY PATIENTS WITH HIGH LEVELS TYPE 2 SYMPTOMS	20
DYSREGULATION OF THE EXPRESSION OF HUMAN RETROVIRUSES IN SYSTEMIC LUPUS ERYTHEMATOSUS	19
CD38 IS OVEREXPRESSED BY IMMUNE CELLS IN CUTANEOUS LUPUS SKIN	19
OUTCOMES OF ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS: A SCOPING REVIEW	18
EFFECT OF CENERIMOD, AN S1P1 MODULATOR, ON FATIGUE IN SLE: RESULTS FROM THE PHASE 2 CARE STUDY	18
DELAYED ONSET OF MALE INFERTILITY AFTER TREATMENT WITH HIGH DOSE OF CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS	18
EFAVALEUKIN ALFA IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A BAYESIAN ADAPTIVE, PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE-RANGING STUDY	18
CONTEMPORARY KIDNEY OUTCOMES AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES	17
THE IMPORTANCE OF TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSING LIBMAN-SACKS ENDOCARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT	17
AN UNUSUAL CASE OF LYMPHOCYTIC ENTEROCOLITIS AND VASCULITIS AS THE INITIAL MANIFESTATION OF SLE	17
ANTI-Β2GLYCOPROTEIN I-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS CAUSE ENDOTHELIAL ACTIVATION	17
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis	16
PRISTANE-INDUCED LUPUS MICE PRESENT INCREASED MEGAKARYOCYTE COUNTS ALONGSIDE OTHER HISTOPATHOLOGICAL FEATURES IN THE SPLENIC TISSUE	16
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis	16
The State of Patient-Reported Outcome Measures in Rheumatology	16
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A	15
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	15
Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use	15
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist	15
Atlantoaxial Subluxation in Patients with Psoriatic Arthritis	15
Inflammation as a Treatment Target in Hand Osteoarthritis: A Review of Previous Studies and Future Perspectives	15
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review	15
Text-Based Messaging to Support Rheumatoid Arthritis Care: An Analysis of the Frequency and Content of Text Messages	15
Current Barriers to Accessing Mental Healthcare Resources for Inflammatory Arthritis Patients and How to Improve Support	14
Modulating the Gut-Joint Axis: The Impact of Anti-TNF Therapy on Gut Microbiota in Ankylosing Spondylitis - A Systematic Review	14
The Uses and Advances in Imaging for Psoriatic Arthritis: A Scoping Review	13
Long-Term Outcomes in Lung Transplant for Anti-Melanoma Differentiation-Associated Gene 5 Antibody Positive Interstitial Lung Disease: A Case Series	13
Development of MOGAD in a Patient with Granulomatosis with Polyangiitis and Giant Cell Arteritis Overlap Syndrome	13
The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis	13
Exploring Causal Relationships of Depression and Psoriatic Disease (Psoriatic Arthritis and Psoriasis) Through Mendelian Randomization	12
Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis	12
Drs. Chung and McMahan reply	12
How Does Juvenile Idiopathic Arthritis Affect the Employment and Usual Activities of Adolescents? The UCAN CAN-DU and CURE International Prospective Study	12
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study	12
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib	12
The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study	12
Negative Health Impacts of Navigating the Healthcare System for Musculoskeletal Conditions: Healthcare User Perspectives	12
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease	12
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus	12
Scrotal Calcinosis in Juvenile Systemic Sclerosis	12
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review	11
DRUG LEVELS AND ANTI-DRUG ANTIBODIES OVER 2 YEARS OF BELIMUMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS	11
VALIDATION OF A SCORE FOR THE PREDICTION OF SERIOUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LATIN AMERICAN LUPUS COHORT	11
IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT	11
CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AT A TERTIARY UNIVERSITY HOSPITAL	11
Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation	11
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation	11

SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS	11
VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS	11
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus	11
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus	11
Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan	11
THE TYPE I IFN SIGNATURE BETWEEN PATIENTS WITH RA AND SLE.	11
ADMINISTRATION OF BELIMUMAB IN EARLY ACTIVE LUPUS PATIENTS HINDERS ACCRUAL OF EULAR/ACR CRITERIA WITHIN THE FIRST 12 MONTHS OF TREATMENT	11
SERUM NEUROFILAMENT LIGHT TO DISTINGUISH AND MONITOR ACTIVITY IN A COHORT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	11
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF PATIENTS AFFECTED BY SLE AND OTHER RHEUMATIC DISEASES (RDS) THROUGH VALIDATED QUESTIONNAIRES	10
GENETICS OF EGFR VARIABILITY AS A PROXY FOR LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	10
INCREASE OF IL10 AND INFA2 ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS	10
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculi	10
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A	10
SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS	10
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY	10
ASSOCIATION BETWEEN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SLE: A REAL-WORLD COHORT STUDY	10
Functional Connectivity and Structural Signatures of the Visual Cortical System in Fibromyalgia: A Magnetic Resonance Imaging Study	10
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment	10
DOES SLEDAI-2K REFLECT THE INTERFERON-ALPHA GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS? PRELIMINARY RESULTS FROM A COHORT	10
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS	10
FACTORS INFLUENCING SUBJECTIVE MENTAL ALTERATIONS: UNRAVELING THE LUPUS BRAIN FOG	10
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies	10
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients	10
Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients	10
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees	9
The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis	9
Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus	9
BRIDGING THE GAP: IDENTIFYING AND ADDRESSING BARRIERS TO CARE FOR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS	9
Formulating Knee Osteoarthritis Management Plans Taking Type 2 Diabetes Into Account: Qualitative Study of Arthritis Therapists Using Theoretical Domains Framework	9
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?	9
Serum Uric Acid: A Murderer or Bystander for Cardiac-related Mortality?	9
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality	9
VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE	9
Unveiling Deficiency of Adenosine Deaminase 2: An Adult Patient With Recurrent Strokes, Vasculitic Ulcers, and Bowel Perforation	9
A Population-based Study of Grade 12 Academic Performance in Adolescents With Childhood-onset Chronic Rheumatic Diseases	9
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases	9
The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative	9
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment	9
Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study	9
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis	9
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study	9
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study	9
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series	9
CARDIAC LUPUS: A DISEASE NOT TO BE NEGLECTED.	8
TYPE 2 LUPUS IS THE MAJOR PREDICTOR OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY OF 200 PATIENTS	8
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists	8
The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases	8
Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry	8
DOWNREGULATION OF YTHDF2 IN THE SPINAL DORSAL HORN CONTRIBUTES TO THE GENESIS OF CHRONIC PAIN INDUCED BY SYSTEMIC LUPUS ERYTHEMATOSUS	8
ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS	8
IMIQUIMOD-INDUCED ONSET OF DISEASE IN LUPUS-PRONE NZB/W F1 MICE	8
Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis	8
A Clinical Audit of Vaccination in Patients Living with Inflammatory Arthritis and Receiving Specialty Medications	8
Elevated Serum Brain Injury Markers Correlate with Disease Features and Interferons in Children with Systemic Lupus Erythematosus	8
MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF 8 CASES	8
EXPEDITING LUPUS CLASSIFICATION OF AT-RISK INDIVIDUALS USING NOVEL TECHNOLOGY: OUTCOMES OF A PILOT STUDY	8
IMPACT OF BELIMUMAB ON EFFICACY, SAFETY AND IMMUNE PHENOTYPES IN REFRACTORY AND ACTIVE LUPUS NEPHRITIS IN REAL-WORLD LOOPS REGISTRY	8
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study	8
Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Preclinical RA Is Mediated by Anti-NET Antibodies	8
Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2B/3 Trials	8
Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study	7
Patient-Provider Communication in Pediatric Rheumatology: A Narrative Review and Presentation of Pilot Data	7
Association Between Depressive Symptoms and Self-Reported Physical Activity in Persons With Knee Osteoarthritis	7
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting	7
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	7
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey	7
Arthritis Mutilans in Psoriatic Arthritis: The Consequences of Delayed Treatment	7
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases	7
Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures	7
Infections in Vasculitis: Can We Create an Epidemic of Change?	7
A Frameshift Mutation ofNLRP12in a Patient With Chronic Recurrent Multifocal Osteomyelitis	7
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study	7
Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study	7
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome	7
An Evaluation of Burnout Among US Rheumatology Fellows: A National Survey	7
Dr. Berti et al reply	7
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	7
Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies	6
A SURVEY OF PATIENTS WITH SLE SUGGESTS LIMITED KNOWLEDGE OF NEPHRITIS UNLESS THERE IS ALREADY CHRONIC KIDNEY DISEASE	6
Getting the Diagnosis Right: What’s in a Name?	6

Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study	6
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis	6
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events	6
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	6
Golimumab for Adherence in Rheumatoid Arthritis (GO FAR): A Multicenter, Prospective, Observational Study of Patients Treated with Golimumab for Rheumatoid Arthritis	6
EFFICACY AND SAFETY OF ELSUBRUTINIB AND UPADACITINIB COMBINATION AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS	6
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk	6
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?	6
DMARD Utilization Patterns in Community-Dwelling Rheumatoid Arthritis Patients: Insights from Linked Primary Care and Pharmaceutical Data	6
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort	6
PROPOSALS FOR DEFINITIONS OF MODERATE AND SEVERE DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. IMPACT ON FLARES, QUALITY OF LIFE, DAMAGE ACCRUAL, HOSPITALIZATIONS AND MORTALITY	6
Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis	6
Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study	6
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus	6
Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex	6
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease	6
ANIFROLUMAB EFFECTS ON RESPONSE TO INFLUENZA VACCINE IN SLE	6
Development of National Clinical Practice Guidelines for Transition in Rheumatology	6
MPO-ANCA Positivity in a Patient with Pyoderma Gangrenosum and Graves’ Disease: A Case Report and Review of the Literature	6
DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIAL	6
EFFICACY AND SAFETY OF TACROLIMUS IN THE MAINTENANCE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS	6
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response	6
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study	6
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe	6
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort	6
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS	6
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS	6
Janus Kinase Inhibitor Exposure During Pregnancy in Immune-Mediated Inflammatory Diseases: A Case Series of 3 Patients	6
Analyzing Gender Disparities in Ankylosing Spondylitis: Exploring the Factors Behind Severe Sacroiliac Joint Disease Without Spinal Involvement	5
Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?	5
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis	5
DisseminatedMycobacterium haemophilumInfection Mimicking Rheumatoid Nodules	5
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network	5
Autoinflammatory Diseases and Vasculitis: The Missing Link	5
Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis	5
PARTNERING WITH ADOLESCENTS AND YOUNG ADULTS WITH CHILDHOOD-ONSET LUPUS TO IMPROVE ENGAGEMENT IN CARE	5
PROTEOMIC ANALYSIS OF SERUM OVER TIME TO FORECAST TREATMENT RESPONSE IN LUPUS NEPHRITIS	5
NONINVASIVE HIGH-THROUGHPUT SERUM PROTEOMICS FOR DISTINGUISHING SUBTYPES OF LUPUS NEPHRITIS	5
Co-Designing a Patient-Facing Dashboard with Patients and Healthcare Providers: Gathering User Input	5
Rapid Review of Transition Outcomes in Youth with Rheumatic Diseases	5
ANTI-C1Q ANTIBODIES AS INDICATORS OF DISEASE ACTIVITY, RENAL INVOLVEMENT, AND NON-SCARRING ALOPECIA IN PATIENTS WITH SLE	5
Degenerative Disc Disease in Young Adults With Psoriatic Arthritis	5
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases	5
Sarcopenia as a Feature of Musculoskeletal Manifestations of Pediatric Crohn’s Disease	5
EXPLORING PHYSICAL ACTIVITY ENGAGEMENT AND SUPPORT IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE IMPACT OF SOCIAL SUPPORT, HEALTHCARE PROVIDER RELATIONSHIPS, AND BUILT ENVIRONMENTS	5
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls	5
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies	5
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey	5
Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis	5
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis	5
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region	5
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry	5
CLINICAL IMPACT OF C-CAR168, A NOVEL ANTI-CD20/BCMA COMPOSITE AUTOLOGOUS CAR T THERAPY, IN REFRACTORY LUPUS NEPHRITIS	5
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group	5
Emergency Department Visits for Ambulatory Care Sensitive Conditions by Persons with Rheumatoid Arthritis: A Population-Based Study	5
DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FOR THERAPEUTIC EVALUATION IN A VIRTUAL POPULATION	5
Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin D: Results from the PASCOD Study, an RA Prevention Protocol	5
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK	5
Bimekizumab Maintained Stringent Clinical Responses Over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies	5
RESPONSE TO HYDROXYCHLOROQUINE IN IMMUNE THROMBOCYTOPENIA IN CHILDHOOD-ONSET SLE	5
Elucidating the Program Theory of a Successful Interdisciplinary Team-Based Model of Rheumatology Care: An Implementation Science Exploratory Case Study	5
ANALYSIS OF PULMONARY COMPLICATIONS IN SLE PATIENTS WITH AND WITHOUT COVID-19: A NATIONAL INPATIENT STUDY	5
Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept	5
Does Age Matter in Psoriatic Arthritis? A Narrative Review	5
Optimizing Care for Pregnancy in Rheumatic Diseases: Barriers and Potential Solutions	5
AUTOIMMUNE DISEASE PREVALENCE IN PEOPLE LIVING WITH HIV AT CIPTO MANGUNKUSUMO GENERAL HOSPITAL: A COHORT STUDY	5
Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment	5
Metabolic Stress Remodeling: Insights into the Role(s) of FOXO1 in Promoting Cancer-Like Changes in Systemic Sclerosis (SSc)	5
50 Years ofThe Journal of Rheumatology	5
DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS	5
A EULAR/ACR (2019) SLE CLASSIFICATION CRITERIA SCORE ≥20 IS A MARKER OF SEVERE DISEASE IN A PREVALENT SLE COHORT FROM THE PORTUGUESE REUMA.PT REGISTRY	5
Immune Checkpoint Inhibitors: A Pediatric Needs Assessment	5
The Road to a New Horizon in Psoriatic Arthritis	5
REAL-WORLD ASSESSMENT OF PATTERNS OF PAIN TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: A PATHWAY VISUALIZATION STUDY USING EHR	5
Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis	5
REDUCED FREQUENCY OF CIRCULATING INTERLEUKIN-16 EXPRESSING CD4+AND CD8+T CELLS ASSOCIATE WITH INCREASED URINARY IL16 LEVELS AND PROMOTE TH1 AND CD8+T CELL MIGRATION IN LUPUS PATIENTS	5
Seronegative Sjögren Syndrome: A Forgotten Entity?	5
NOVEL 3-BASE OLIGONUCLEOTIDE THERAPEUTIC SOF-SKN™ ANTAGONISES TLR7/8 IN AUTOIMMUNE SKIN DISEASE	5
Sialic Acid Binding Ig-Like Lectin 1 is a Biomarker of Disease Activity in Autoimmune Inflammatory Myopathies	4
Sex Effect in Psoriatic Arthritis	4
A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF CB-010, A NEXT-GENERATION CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY, IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (GALLOP)	4
SAFETY OF FERTILITY TREATMENTS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A FRENCH PROSPECTIVE POPULATION-BASED STUDY	4
COMPLEMENTARY LUPUS-SPECIFIC INDEXES INFORMED BY SELECT IMMUNE MEDIATORS CHARACTERIZE RISK OF CONCURRENT DISEASE ACTIVITY AND FUTURE IMPENDING FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS	4
Developing and Evaluating a Laboratory-Based Frailty Index for the Prediction of Long-Term Health Outcomes in Systemic Lupus Erythematosus	4
Preliminary Results of a Pilot Randomized Controlled Trial: Feasibility and Acceptability of a Virtual Adolescent Self-Management Program for Juvenile Idiopathic Arthritis	4
Characterization of Fecal Microbiota in Ankylosing Spondylitis: Pathogenesis Insights and Therapeutic Opportunities - A Systematic Review	4
CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: PREGNANCY AND BIRTH OUTCOMES IN ONTARIO	4
MRL-LPR MICE DISPLAY ALTERED NOCICEPTION: A POSSIBLE MODEL FOR LUPUS PERIPHERAL NEUROPATHY	4
ANTINEUTROPHIL EXTRACELLULAR TRAPS (NET) ANTIBODIES AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND SYSTEMIC LUPUS ERYTHEMATOSUS CLINICAL PHENOTYPES	4
INTRA-RENAL INVOLVEMENT IN PRIMARY ANTIPHOSPHOLIPID ANTIBODIES SYNDROME: DATA FROM 2 ITALIAN CENTERS	4
Bullous Esophagitis with Severe Stricturing Disease, a Case Study of a Rare Systemic Lupus Erythematosus Manifestation	4
Lung Transplantation Outcomes of Patients with Interstitial Pneumonia with Autoimmune Features	4
COMPARATIVE ANALYSIS OF BELIMUMAB, ANIFROLUMAB, AND RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RETROSPECTIVE STUDY OF CLINICAL AND ANALYTICAL OUTCOMES	4
SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY	4
Entrustable Professional Activities for Musculoskeletal Ultrasound Training in a Canadian Rheumatology Residency Program: A Pilot Study	4